Meet The CEO
Dr. Bene Ekine-Afolabi
Our Founder and CEO
She is a graduate of River State University of Science & Technology in Applied Biology (Medical Microbiology), with an MRes degree at University of East London, United Kingdom. She studied towards her PhD and worked at the Department of Natural Sciences as visiting lecturer in Haematology cancer, Middlesex University, UK.
Trained in Practical Approach to Toxicology in Drug Development (American College of Toxicology/British Toxicology Society). She received a part-sponsored training award in Cancer Biology & Therapeutics at Harvard Medical school, graduated with a Distinction (among the top six in class). Bene does research in Microbiology, Molecular Biology and Cancer Research; her current research focuses on the Investigation of molecular mechanism of colorectal cancer development, EMT, and cell death. Bene’s current project involves lead compound optimization in the development of novel therapeutic for colorectal cancer.
Meet The Team
Our team consists of highly qualified and motivated professionals, who are all experts in their field. With many years of experience in the industry, they have the expertise to provide comprehensive, first-rate services..
Director & Business Manager
Engr. Olabode Afolabi
A seasoned HSE Professional with over 25 years of experience in the Oil & Gas Industry. He has 13 years of experience in Lead HSE Project roles across Shell Nigeria. A few projects he has handled include the Bonga South West Aparo project, Assa North and Nun River projects for Shell Nigeria. With more than eight years of project management experience in Civil Infrastructure and the Oil & Gas sector, he brings a wealth of business knowledge and experience.
Chair of the Board
Prof Bene Willie-Abbey
An experienced Lecturer with experience as a Postdoctoral Research Fellow at the University of Nottingham. She has many well-researched articles in reputable national and international journals. Her work is well recognised as a recipient of over 20 professional and social awards. Her experience as a pioneer member of different institutions has built profound leadership qualities. Her qualifications include a PhD in Nutritional Biochemistry, a Bachelor of Science B.Sc (Hons) in Agricultural and an MBA Essentials.
Board Member
Prof Sam Douglas Abbey
An author, lecturer, Chartered Biologist, and widely published researcher. Accomplished in Medical Microbiologist/Biomedical Scientist, his speciality is in Medical Mycology. He is a member of several professional bodies, such as the institute of Biomedical Science London. To date, he is a professor on contract at the Rivers State University of Science & Technology. His qualifications include a Ph. D in Microbiology.
Chief Medical Officer
Dr John Bolodeoku
A seasoned medical adviser, director, and officer with a Doctor of Philosophy from the University of Oxford. His qualifications include a Bachelor of Medicine, Master of Science, Master of Business Administration and more. He is a multi-award-winning lecturer, author and recognised fellow at the Royal Society of Biology and Royal College of Pathology. His experience providing medical leadership and management is invaluable.
COO/Director of Operation
Prof Solomon Rotimi
A distinguished Professor, lecturer and published scholar interested in clinical biochemistry and genomics. His qualifications include a BSc, MSc, and PhD. He is an experienced director and co-chair in organisations such as the African Organization for Research and Training in Cancer Research. As an accomplished reviewer, he upholds the integrity of journals by identifying inaccurate research.
Colorectal Cancer Consultant
Dr Ademola Adeyeye
Dr Ademola is a professor and general surgeon with a specialisation in gastrointestinal surgery. His qualifications include an MBBS, PGDE, Masters in Clinical Trials and PhD in Surgical Oncology. He was the First European Board-Certified Oncologist from SubSaharan Africa. As the Vice president and Clinical researcher for the Nigerian Society ColoRectal Disorders(NSCRD), he is highly experienced.
Clinical Pharmacology Consultant
Prof Anoka Njan
With over 25 years of experience in the pharmaceutical sector, he is a skilled lecturer, researcher and fellow. He held an International Fellowship with the World Health Organization (WHO), TICA and the Society of Toxicology. In 2011 he was presented with a fellowship award by AstraZeneca. His qualifications include a Bachelor of Physiology, Master of Pharmacology, Certificate in Clinical Res Meth and PhD.
MILESTONE
ZEAB Compound patent application filed in Mar 2019 with patent application number 1902498.3
Toxicity & ADME (in silico & invitro) completed Dec 2019
ZEAB eight design models f or treatment of Colorectal cancer completed in Jul 2020
GST Polymorphism in UK Population (Pilot Study) 2021
Exploring Homeostasis Network & Biomarkers 2021
Non-Coding RNA Expression (Pilot study) 2021
ZEAB Knop (Health Digest) Q2 2022
UK R&D Assurance Approval Q3 2022
Hospital Project (planning and pre -project activities) Q2 2022
Diagnostics (HLA, Vit D, Diabetes, Prostate cancer) Q4 2023
Lagos mainland hospital & Kenya Hospital Intro services Q3 2022
Further Designs & Synthesis Q42022
Ex-vivo pharmacology, Metabolome, Sequencing Q42022, Q12023-24
Preclinical Animal Model toxicity Q42023
First in Human Trial (Phase I Safety) Q42024
Poison Control Centre Q42023
Colorectal Cancer Screening Device Q1 2024
ZEAB oncology Diagnostic: Launching Q22024
Phase II (Efficacy) Q32025
Ek o Atlantic Hospital; Launching Q42027
Phase III (Efficacy & Large Group) Q32026
We need your consent to load the translations
We use a third-party service to translate the website content that may collect data about your activity. Please review the details in the privacy policy and accept the service to view the translations.